Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.

[1]  P. Verbeke,et al.  Penicillin Kills Chlamydia following the Fusion of Bacteria with Lysosomes and Prevents Genital Inflammatory Lesions in C. muridarum-Infected Mice , 2013, PloS one.

[2]  A. Maurelli,et al.  A new metabolic cell wall labeling method reveals peptidoglycan in Chlamydia trachomatis , 2013, Nature.

[3]  M. Burton,et al.  Research Online , 2022 .

[4]  N. Ip,et al.  Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. , 2013, Bioorganic & medicinal chemistry.

[5]  Markus K. Dahlgren,et al.  Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion , 2012, The Journal of Antibiotics.

[6]  Xiaole Kong,et al.  Design of iron chelators with therapeutic application. , 2012, Dalton transactions.

[7]  A. Albrecht-Gary,et al.  Pyochelin, a siderophore of Pseudomonas aeruginosa: physicochemical characterization of the iron(III), copper(II) and zinc(II) complexes. , 2012, Dalton transactions.

[8]  Igor V. Tetko,et al.  Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information , 2011, J. Comput. Aided Mol. Des..

[9]  J. Harrington,et al.  Iron sequestration by small molecules: Thermodynamic and kinetic studies of natural siderophores and synthetic model compounds , 2010 .

[10]  P. Keyser,et al.  Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. , 2010, International journal of antimicrobial agents.

[11]  C. Walsh,et al.  Three siderophores from one bacterial enzymatic assembly line. , 2009, Journal of the American Chemical Society.

[12]  J. El Hage Chahine,et al.  Kinetics and thermodynamics of complex formation with iron of a new series of dicatecholspermidine siderophore-like ligands. , 2008, Journal of inorganic biochemistry.

[13]  Anatoly V. Slepenkin,et al.  Reversal of the Antichlamydial Activity of Putative Type III Secretion Inhibitors by Iron , 2007, Infection and Immunity.

[14]  Richard Ting,et al.  Triggering DNAzymes with light: a photoactive C8 thioether-linked adenosine. , 2004, Journal of the American Chemical Society.

[15]  M. Wiedmann-Al-Ahmad,et al.  Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis. , 2001, Journal of medical microbiology.

[16]  J. Raulston.  Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins , 1997, Infection and immunity.

[17]  P. Bavoil,et al.  Type III secretion genes identify a putative virulence locus of Chlamydia , 1997, Molecular microbiology.

[18]  H. Boukhalfa,et al.  O-TRENSOX: A Promising Water-Soluble Iron Chelator (Both FeIII and FeII) Potentially Suitable for Plant Nutrition and Iron Chelation Therapy , 1995 .

[19]  L. Gram,et al.  Pseudomonine, an isoxazolidone with siderophoric activity from Pseudomonas fluorescens AH2 isolated from Lake Victorian Nile perch , 1995 .

[20]  M. Miller,et al.  Spermexatin and spermexatol: new synthetic spermidine-based siderophore analogues. , 1989, Journal of medicinal chemistry.

[21]  F. B. Gordon,et al.  Susceptibility of Chlamydia to Antibacterial Drugs: Tests in Cell Cultures , 1972, Antimicrobial Agents and Chemotherapy.

[22]  J. Moulder,et al.  INHIBITION OF THE GROWTH OF AGENTS OF THE PSITTACOSIS GROUP BY d-CYCLOSERINE AND ITS SPECIFIC REVERSAL BY d-ALANINE , 1963, Journal of bacteriology.

[23]  M. Ravaoarinoro,et al.  Chlamydia trachomatis persistence: an update. , 2006, Microbiological research.

[24]  R. Stephens.  Genomic Autobiographies of Chlamydiae , 1999 .